US Patent Issued to Shenzhen Porshealth Bioengineering on Sept. 2 for "Lactobacillus acidophilus GOLDGUT-LA100 having functions of lipid lowering, blood glucose lowering and weight loss and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,487, issued on Sept. 2, was assigned to Shenzhen Porshealth Bioengineering Co. Ltd. (Shenzhen, China).

"Lactobacillus acidophilus GOLDGUT-LA100 having functions of lipid lowering, blood glucose lowering and weight loss and application thereof" was invented by Yanyi Zheng (Shenzhen, China), Silu Zhang (Shenzhen, China), Guoxun Xiao (Shenzhen, China), Tengxun Zhang (Shenzhen, China), Yuebiao Feng (Shenzhen, China), Xin Teng (Shenzhen, China) and Song Huang (Shenzhen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the technical field of microorganisms, in particular to a Lactobacillus acidophilus GOLDGUT-LA100 hav...